Daniel Pedregal-Mallo

8PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples remote healthAllergyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 06, 2026
Prognostic Utility of Hematological Inflammatory Markers in Stratifying Cancer Risk in Laryngeal Premalignant Lesions.

María Puente-Vérez, Raúl Martín-González, Daniel Pedregal-Mallo

|Jan 10, 2024
Prognostic value of preoperative inflammatory ratios in early glottic cancer treated with transoral laser surgery.

Luis Juesas Iglesias, Mario Sánchez-Canteli, Daniel Pedregal Mallo

|May 08, 2021
Asymptomatic swallowing disorders may be present in individuals with laryngeal and hypopharyngeal cancer treated with chemo-radiotherapy.

César Álvarez-Marcos, Andrea Vicente Benito, Agueda Gayol Fernández

|Jul 09, 2020
Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas.

Daniel Pedregal-Mallo, Francisco Hermida-Prado, Rocío Granda-Díaz

|Feb 06, 2020
Impact of immunotherapy on quality of life in patients with house dust mite allergic rhinitis.

Daniel Pedregal-Mallo, Esteban Pacheco, Juan Pablo Rodrigo

Pageof 2